PHOENIX, Aug. 31, 2017 /PRNewswire/ -- Avella just announced that it has launched a new mobile app aimed at care providers who manage patients dealing with chronic pain or an addiction to pain medication. This Pain and Addiction Management Mobile App will provide much-needed guidance and support for providers in the wake of the opioid epidemic and tightening regulations around the prescribing of certain pain medications.
More than twenty-five million Americans, or more than one in ten people, experience chronic pain daily according to the National Institutes for Health. This legitimate need for pain relief is exceedingly difficult to manage given the inherent risks involved in prescribing powerful narcotics. In 2015, opioid drug overdoses led to the death of 33,000 people in this country as reported by the CDC, greater than any year on record. Approximately half of these deaths involved a prescription opioid.
In response to this crisis, many new non-narcotic medications are now being introduced to treat chronic pain, along with therapies designed to help patients addicted to prescription opioids. Given all of these options now available, along with an increasingly regulated prescribing landscape, Avella identified a need to help providers identify the most appropriate, safe and effective medications for their patients.
Avella's new mobile app provides information about a variety of pain and addiction management medications available from different manufacturers, all in one place. Prescribers can search for clinical information by medication name or category. Users can also access powerful tools like opioid converters, which can be used to transition patients to a new medication while maintaining safety and efficacy of treatment, along with drug dosage calculators. Evidence-based prescribing guidelines from the Centers for Disease Control and Prevention, the American Society of Addiction Medicine and other renowned organizations are also easily accessible within the app.
"Prescribing pain medications has always been a difficult task given the safety risks, addiction potential and side effects of certain powerful narcotics," said Eric Sredzinski, Pharm.D, EVP of Clinical Affairs and Quality Assurance Program Director for Avella. "Today it is more challenging than ever, which is why we're looking to support our provider partners as they help patients manage chronic pain while preventing the devastating impact of opioid addiction."
The Pain and Addiction Management Mobile App from Avella is available on the Google Play or Apple App store. Providers can search for "Pain Management Medication App." For more information, visit: https://www.avella.com/pain-mobile-app
About Avella Specialty Pharmacy
Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2016, Avella was named Specialty Pharmacy of the Year by NASP, a nationally recognized pharmacy trade committee. Inc. Magazine's 2016 list of the 5,000 fastest-growing private companies in the country included Avella for the tenth consecutive year and also recognized Avella as the fastest-growing woman-led company in 2015. In addition, the Arizona Corporate Excellence Awards named Avella Specialty Pharmacy as the second fastest-growing private company based in the state in 2016. For more information, please visit www.avella.com.